Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 402-408

  Lee, Hyunghee ^a   Park, Dongmin ^a   Yoon, Michung ^a  

^a Mokwon University   (South Korea)

Author keywords

Adipose tissue growth; Angiogenesis; High fat diet; MMP; Obesity; Panax ginseng

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; GINSENG EXTRACT; MATRIX METALLOPROTEINASE; MESSENGER RNA; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULOTROPIN A;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; FOOD INTAKE; GINSENG; HIGH FAT DIET INDUCED OBESITY; HISTOLOGY; LIPID DIET; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; ZYMOGRAPHY;

ADIPOCYTES; ADIPOSE TISSUE; ANGIOGENESIS INHIBITORS; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; FIBROBLAST GROWTH FACTOR 2; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PANAX; RNA, MESSENGER; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS; PANAX GINSENG;

EID: 84872825289     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.052     Document Type: Article

References (45)

1. Armstrong L.C., Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol. 2003, 22:63-71.
2. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 1999, 58:1685-1693.
3. Attele A.S., Zhou Y.P., Xie J.T., Wu J.A., Zhang L., Dey L., Pugh W., Rue P.A., Polonsky K.S., Yuan C.S. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002, 51:1851-1858.
4. Banz W.J., Iqbal M.J., Bollaert M., Chickris N., James B., Higginbotham D.A., Peterson R., Murphy L. Ginseng modifies the diabetic phenotype and genes associated with diabetes in the male ZDF rat. Phytomedicine 2007, 14:681-689.
5. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2:737-744.
6. Bouloumié A., Lolmède K., Sengenès C., Galitzky J., Lafontan M. Angiogenesis in adipose tissue. Ann. Endocrinol. 2002, 63:91-95.
7. Bouloumié A., Sengenès C., Portolan G., Galitzky J., Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001, 50:2080-2086.
8. Bråkenhielm E., Cao R., Gao B., Angelin B., Cannon B., Parini P., Cao Y. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 2004, 94:1579-1588.
9. Cao Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 2007, 117:2362-2368.
10. Cao Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov. 2010, 9:107-115.
11. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
12. Chavey C., Mari B., Monthouel M.N., Bonnafous S., Anglard P., Van Obberghen E., Tartare-Deckert S. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J. Biol. Chem. 2003, 278:11888-11896.
13. Crandall D.L., Hausman G.J., Kral J.G. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997, 4:211-232.
14. Gabison E.E., Hoang-Xuan T., Mauviel A., Menashi S. Metalloproteinases and angiogenesis. Pathol. Biol. 2003, 51:161-166.
15. Gillis C.N. Panax ginseng pharmacology: a nitric oxide link?. Biochem. Pharmacol. 1997, 54:1-8.
16. Ho Y.L., Li K.C., Chao W., Chang Y.S., Huang G.J. Korean red ginseng suppresses metastasis of human hepatoma SK-hep1 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen activator. Evid. Based Complement. Altern. Med. 2012, 2012:965846.
17. Jeong A., Lee H.J., Jeong S.J., Lee H.J., Lee E.O., Bae H., Kim S.H. Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells. Biol. Pharm. Bull. 2010, 33:945-950.
18. Jeong S., Yoon M. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp. Mol. Med. 2009, 41:397-405.
19. Jung S.H., Woo M.S., Kim S.Y., Kim W.K., Hyun J.W., Kim E.J., Kim D.H., Kim H.S. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int. J. Cancer 2006, 118:490-497.
20. Kawaguchi N., Toriyama K., Nicodemou-Lena E., Inou K., Torii S., Kitagawa Y. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 1998, 95:1062-1066.
21. Kim Y.M., An J.J., Jin Y.J., Rhee Y., Cha B.S., Lee H.C., Lim S.K. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732. J. Mol. Endocrinol. 2007, 38:455-465.
22. Kim J.H., Hahm D.H., Yang D.C., Kim J.H., Lee H.J., Shim I. Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat. J. Pharmacol. Sci. 2005, 97:124-131.
23. Kim M.Y., Park B.Y., Lee H.S., Park E.K., Hahm J.C., Lee J., Hong Y., Choi S., Park D., Lee H., Yoon M. The anti-angiogenic herbal composition Ob-X inhibits adipose tissue growth in obese mice. Int. J. Obes. 2010, 34:820-830.
24. Lee H.J., Lee Y.H., Park S.K., Kang E.S., Kim H.J., Lee Y.C., Choi C.S., Park S.E., Ahn C.W., Cha B.S., Lee K.W., Kim K.S., Lim S.K., Lee H.C. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism 2009, 58:1170-1177.
25. Lee S.H., Lee H.J., Lee Y.H., Lee B.W., Cha B.S., Kang E.S., Ahn C.W., Park J.S., Kim H.J., Lee E.Y., Lee H.C. Korean red ginseng (Panax ginseng) improves insulin sensitivity in high fat fed Sprague-Dawley rats. Phytother. Res. 2012, 26:142-147.
26. Lijnen H.R., Demeulemeester D., Van Hoef B., Collen D., Maquoi E. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb. Haemost. 2003, 89:249-255.
27. Lijnen H.R., Maquoi E., Hansen L.B., Van Hoef B., Frederix L., Collen D. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 2002, 22:374-379.
28. Lijnen H.R., Van Hoef B., Kemp D., Collen D. Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity. Biochim. Biophys. Acta 2007, 1770:1369-1373.
29. Liu T.G., Huang Y., Cui D.D., Huang X.B., Mao S.H., Ji L.L., Song H.B., Yi C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009, 9:250.
30. Lü J.M., Yao Q., Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr. Vasc. Pharmacol. 2009, 7:293-302.
31. Maquoi E., Munaut C., Colige A., Collen D., Lijnen H.R. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002, 51:1093-1101.
32. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 1998, 101:1354-1361.
33. Park H.Y., Kwon H.M., Lim H.J., Hong B.K., Lee J.Y., Park B.E., Jang Y., Cho S.Y., Kim H.S. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 2001, 33:95-102.
34. Park D., Yoon M. Compound K, a novel ginsenoside metabolite, inhibits adipocyte differentiation in 3T3-L1 cells: involvement of angiogenesis and MMPs. Biochem. Biophys. Res. Commun. 2012, 422:263-267.
35. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., Folkman M.J. Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. USA 2002, 99:10730-10735.
36. Sadowski T., Dietrich S., Koschinsky F., Sedlacek R. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol. Biol. Cell 2003, 14:4569-4580.
37. Sato K., Mochizuki M., Saiki I., Yoo Y.C., Samukawa K., Azuma I. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull. 1994, 17:635-639.
38. Sengupta S., Toh S.A., Sellers L.A., Skepper J.N., Koolwijk P., Leung H.W., Yeung H.W., Wong R.N., Sasisekharan R., Fan T.P. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004, 110:1219-1225.
39. Soldati F., Sticher O. HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. 2nd communication. Planta Med. 1980, 39:348-357.
40. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 1999, 103:1237-1241.
41. Van Hul M., Lijnen H.R. Matrix metalloproteinase inhibition impairs murine adipose tissue development independently of leptin. Endocr. J. 2011, 58:101-107.
42. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
43. Xu T.M., Cui M.H., Xin Y., Gu L.P., Jiang X., Su M.M., Wang D.D., Wang W.J. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis. Chin. Med. J. 2008, 121:1394-1397.
44. Yoon M., Kim M.Y. The anti-angiogenic herbal composition Ob-X from Morus alba, Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice. Pharm. Biol. 2011, 49:614-619.
45. Yue P.Y., Wong D.Y., Wu P.K., Leung P.Y., Mak N.K., Yeung H.W., Liu L., Cai Z., Jiang Z.H., Fan T.P., Wong R.N. The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem. Pharmacol. 2006, 72:437-445.